Definitive Healthcare Corp. (DH)
NASDAQ: DH · Real-Time Price · USD
4.920
-0.270 (-5.20%)
At close: Feb 21, 2025, 4:00 PM
4.735
-0.185 (-3.76%)
After-hours: Feb 21, 2025, 6:41 PM EST
Definitive Healthcare Stock Forecast
Stock Price Forecast
The 10 analysts with 12-month price forecasts for Definitive Healthcare stock have an average target of 6.15, with a low estimate of 4.00 and a high estimate of 10. The average target predicts an increase of 25.00% from the current stock price of 4.92.
Analyst Consensus: Hold
* Price targets were last updated on Jan 13, 2025.
Analyst Ratings
The average analyst rating for Definitive Healthcare stock from 11 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 7 | 7 | 7 | 8 | 7 | 7 |
| Sell | 1 | 1 | 1 | 1 | 2 | 2 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 10 | 11 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Jan 16, 2025 |
| Barclays | Barclays | Hold → Sell Downgrades $4 | Hold → Sell | Downgrades | $4 | -18.70% | Jan 13, 2025 |
| Stephens & Co. | Stephens & Co. | Hold Initiates $5 | Hold | Initiates | $5 | +1.63% | Dec 20, 2024 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Nov 8, 2024 |
| BTIG | BTIG | Strong Buy Initiates $7 | Strong Buy | Initiates | $7 | +42.28% | Sep 17, 2024 |
Financial Forecast
Revenue This Year
257.93M
from 251.42M
Increased by 2.59%
Revenue Next Year
248.30M
from 257.93M
Decreased by -3.73%
EPS This Year
0.35
from -1.79
EPS Next Year
0.30
from 0.35
Decreased by -13.78%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 263.3M | 262.2M | 275.2M |
| Avg | 257.9M | 248.3M | 257.6M |
| Low | 245.0M | 233.2M | 237.2M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 4.7% | 1.7% | 10.8% |
| Avg | 2.6% | -3.7% | 3.7% |
| Low | -2.6% | -9.6% | -4.5% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 0.38 | 0.39 | 0.44 |
| Avg | 0.35 | 0.30 | 0.34 |
| Low | 0.31 | 0.22 | 0.21 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | 10.1% | 44.9% |
| Avg | - | -13.8% | 10.4% |
| Low | - | -38.9% | -32.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.